Even Utah Is Falling in Love with Psychedelics
Nobody ever thinks of ultra-conservative Utah as a liberal stronghold. But one company there has already joined companies in California and Arizona in administering psychedelic treatments as a novel solution to depression. And that could mean the legal psychedelics market is poised to explode.
Here's how you could get in on the ground floor
George W. Lemaitre, insider at LeMaitre Vascular

George W. Lemaitre Insider Information

George LeMaitre currently serves as chairman and CEO of LeMaitre Vascular Inc. 

LeMaitre Vascular provides devices, implants and services for the treatment of peripheral vascular disease, a disease that affects more than 200 million people worldwide. LeMaitre has been the CEO and served as part of the company’s board of directors since 1992, and as its chairman since 2004. 

In his previous career, LeMaitre worked for Lehman Brothers as an investment banking analyst. He has also spent time at McCown De Leeuw as an associate of the leveraged buyout firm, and at Connecticut National Bank as a credit analyst. 

LeMaitre holds a bachelor’s degree in history from Stanford University and an M.B.A. from the Stanford Graduate School of Business.

What is George W. Lemaitre's net worth?

The estimated net worth of George W. Lemaitre is at least $140.78 million as of May 12th, 2021. Mr. Lemaitre owns 2,516,188 shares of LeMaitre Vascular stock worth more than $140,780,719 as of August 3rd. This net worth estimate does not reflect any other assets that Mr. Lemaitre may own.

How do I contact George W. Lemaitre?

The corporate mailing address for Mr. Lemaitre and other LeMaitre Vascular executives is 63 SECOND AVENUE, BURLINGTON MA, 01803. LeMaitre Vascular can also be reached via phone at 781-221-2266.

Has George W. Lemaitre been buying or selling shares of LeMaitre Vascular?

George W. Lemaitre has not been actively trading shares of LeMaitre Vascular over the course of the past ninety days. Most recently, George W. Lemaitre sold 20,951 shares of the business's stock in a transaction on Wednesday, May 12th. The shares were sold at an average price of $48.12, for a transaction totalling $1,008,162.12. Following the completion of the sale, the chief executive officer now directly owns 2,516,188 shares of the company's stock, valued at $121,078,966.56.

Who are LeMaitre Vascular's active insiders?

LeMaitre Vascular's insider roster includes Trent Kamke (Senior Vice President, Operations), and George Lemaitre (CEO).

Are insiders buying or selling shares of LeMaitre Vascular?

In the last twelve months, LeMaitre Vascular insiders bought shares 1 times. They purchased a total of 7,074 shares worth mmore than $200,547.90. In the last twelve months, insiders at the medical instruments supplier sold shares 26 times. They sold a total of 570,031 shares worth mmore than $25,119,111.48. The most recent insider tranaction occured on June, 15th when Trent G Kamke Insider bought 876 shares worth more than $50,816.76. Insiders at LeMaitre Vascular own 14.1 % of the company.

Information on this page was last updated on 6/15/2021.

George W. Lemaitre Insider Trading History at LeMaitre Vascular

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/12/2021Sell20,951$48.12$1,008,162.122,516,188View SEC Filing Icon  
5/10/2021Sell7,200$49.87$359,064.002,592,425View SEC Filing Icon  
5/5/2021Sell31,576$51.68$1,631,847.682,667,945View SEC Filing Icon  
5/3/2021Sell25,000$51.31$1,282,750.002,667,945View SEC Filing Icon  
3/10/2021Sell2,100$49.76$104,496.002,692,833View SEC Filing Icon  
3/3/2021Sell48,150$51.20$2,465,280.002,796,567View SEC Filing Icon  
3/1/2021Sell42,869$51.41$2,203,895.292,796,567View SEC Filing Icon  
11/20/2020Sell2,000$37.69$75,380.002,779,820View SEC Filing Icon  
11/18/2020Sell2,000$38.09$76,180.002,779,820View SEC Filing Icon  
11/16/2020Sell2,000$38.12$76,240.002,779,820View SEC Filing Icon  
11/9/2020Sell134,312$36.60$4,915,819.202,779,820View SEC Filing Icon  
10/29/2020Sell55,792$35.27$1,967,783.842,951,341View SEC Filing Icon  
9/25/2020Sell724$33.98$24,601.522,962,654View SEC Filing Icon  
9/23/2020Sell6,060$33.65$203,919.002,962,654View SEC Filing Icon  
1/13/2020Sell1,939$37.55$72,809.452,939,726View SEC Filing Icon  
1/9/2020Sell3,023$37.42$113,120.662,952,166View SEC Filing Icon  
1/7/2020Sell27,302$36.61$999,526.222,952,166View SEC Filing Icon  
12/27/2019Sell4,894$36.45$178,386.302,979,468View SEC Filing Icon  
12/16/2019Sell4,759$36.40$173,227.602,980,433View SEC Filing Icon  
12/4/2019Sell11,241$36.32$408,273.122,985,192View SEC Filing Icon  
11/25/2019Sell24,200$36.12$874,104.003,023,539View SEC Filing Icon  
11/8/2019Sell16,051$33.53$538,190.033,024,394View SEC Filing Icon  
11/4/2019Sell5,519$34.50$190,405.503,054,069View SEC Filing Icon  
11/1/2019Sell14,684$34.86$511,884.243,054,069View SEC Filing Icon  
10/30/2019Sell9,921$35.53$352,493.133,080,470View SEC Filing Icon  
10/28/2019Sell7,348$35.53$261,074.443,089,687View SEC Filing Icon  
10/24/2019Sell7,068$37.17$262,717.563,089,687View SEC Filing Icon  
9/13/2019Sell4,891$35.03$171,331.733,135,398View SEC Filing Icon  
9/11/2019Sell332$34.67$11,510.443,135,398View SEC Filing Icon  
8/1/2019Sell10,000$32.90$329,000.003,135,730View SEC Filing Icon  
7/30/2019Sell2,000$32.54$65,080.003,135,730View SEC Filing Icon  
7/25/2019Sell66,037$34.45$2,274,974.653,171,124View SEC Filing Icon  
8/22/2018Sell14,180$37.61$533,309.803,118,266View SEC Filing Icon  
7/27/2018Sell39,820$37.34$1,486,878.803,085,291View SEC Filing Icon  
7/25/2018Sell22,000$37.26$819,720.003,085,291View SEC Filing Icon  
6/19/2018Sell15,000$37.07$556,050.003,073,802View SEC Filing Icon  
6/15/2018Sell8,000$37.04$296,320.003,073,802View SEC Filing Icon  
6/4/2018Sell4,821$34.70$167,288.703,086,623View SEC Filing Icon  
6/1/2018Sell35,000$34.50$1,207,500.003,086,623View SEC Filing Icon  
5/23/2018Sell30,000$33.05$991,500.003,157,009View SEC Filing Icon  
5/21/2018Sell8,700$34.07$296,409.003,157,009View SEC Filing Icon  
5/15/2018Sell4,672$33.43$156,184.963,165,709View SEC Filing Icon  
5/11/2018Sell672$33.91$22,787.523,165,709View SEC Filing Icon  
3/7/2018Sell30,000$36.19$1,085,700.003,180,709View SEC Filing Icon  
3/5/2018Sell45,000$34.66$1,559,700.003,225,709View SEC Filing Icon  
3/2/2018Sell15,000$34.55$518,250.003,225,709View SEC Filing Icon  
2/28/2018Sell5,700$35.56$202,692.003,259,263View SEC Filing Icon  
2/26/2018Sell42,036$35.68$1,499,844.483,259,263View SEC Filing Icon  
8/30/2017Sell15,000$37.13$556,950.003,325,508View SEC Filing Icon  
8/29/2017Sell15,000$36.72$550,800.003,325,508View SEC Filing Icon  
8/28/2017Sell30,000$36.43$1,092,900.003,325,508View SEC Filing Icon  
8/25/2017Sell40,000$33.89$1,355,600.003,390,508View SEC Filing Icon  
8/24/2017Sell15,000$33.97$509,550.003,390,508View SEC Filing Icon  
8/23/2017Sell5,000$33.91$169,550.003,390,508View SEC Filing Icon  
8/11/2017Sell21,300$32.90$700,770.003,405,508View SEC Filing Icon  
8/10/2017Sell11,300$32.79$370,527.003,405,508View SEC Filing Icon  
8/9/2017Sell30,000$33.65$1,009,500.003,436,808View SEC Filing Icon  
8/8/2017Sell10,000$34.02$340,200.003,436,808View SEC Filing Icon  
8/7/2017Sell10,000$33.62$336,200.003,436,808View SEC Filing Icon  
8/3/2017Sell58,700$33.97$1,994,039.003,471,808View SEC Filing Icon  
5/18/2017Sell21,225$30.11$639,084.753,386,295View SEC Filing Icon  
5/10/2017Sell63,622$30.98$1,971,009.563,450,815View SEC Filing Icon  
5/9/2017Sell34,517$30.67$1,058,636.393,450,815View SEC Filing Icon  
5/8/2017Sell9,102$31.12$283,254.243,450,815View SEC Filing Icon  
5/3/2017Sell87,342$32.35$2,825,513.703,484,149View SEC Filing Icon  
3/1/2017Sell10,000$22.36$223,600.003,451,694View SEC Filing Icon  
2/28/2017Sell3,000$22.27$66,810.003,451,694View SEC Filing Icon  
2/27/2017Sell5,000$22.31$111,550.003,451,694View SEC Filing Icon  
9/8/2016Sell30,000$20.48$614,400.003,395,063View SEC Filing Icon  
9/2/2016Sell60,037$18.30$1,098,677.103,443,098View SEC Filing Icon  
8/24/2016Sell6,800$17.49$118,932.003,491,564View SEC Filing Icon  
8/23/2016Sell19,664$17.43$342,743.523,491,564View SEC Filing Icon  
8/22/2016Sell8,927$17.39$155,240.533,491,564View SEC Filing Icon  
8/15/2016Sell15,896$17.53$278,656.883,512,839View SEC Filing Icon  
8/9/2016Sell5,460$17.41$95,058.603,516,387View SEC Filing Icon  
8/4/2016Sell4,540$17.65$80,131.003,516,387View SEC Filing Icon  
6/8/2016Sell19,189$15.01$288,026.893,521,849View SEC Filing Icon  
6/7/2016Sell9,100$15.02$136,682.003,521,849View SEC Filing Icon  
6/6/2016Sell900$15.06$13,554.003,521,849View SEC Filing Icon  
5/18/2016Sell2,944$15.23$44,837.123,522,749View SEC Filing Icon  
5/16/2016Sell1,740$15.49$26,952.603,522,749View SEC Filing Icon  
5/13/2016Sell7,451$15.45$115,117.953,522,749View SEC Filing Icon  
5/9/2016Sell110,189$16.17$1,781,756.133,549,133View SEC Filing Icon  
11/17/2015Sell30,000$14.15$424,500.003,698,385View SEC Filing Icon  
8/13/2015Sell33,059$13.41$443,321.19View SEC Filing Icon  
5/18/2015Sell20,132$10.01$201,521.32View SEC Filing Icon  
5/7/2015Sell70,984$9.72$689,964.48View SEC Filing Icon  
1/26/2015Sell3,486$7.85$27,365.10View SEC Filing Icon  
1/5/2015Sell18,447$7.74$142,779.78View SEC Filing Icon  
12/30/2014Sell18,067$7.58$136,947.86View SEC Filing Icon  
12/29/2014Sell5,058$7.59$38,390.22View SEC Filing Icon  
12/26/2014Sell6,693$7.53$50,398.29View SEC Filing Icon  
12/24/2014Sell2,900$7.60$22,040.00View SEC Filing Icon  
12/10/2014Sell1,117$7.40$8,265.80View SEC Filing Icon  
12/9/2014Sell1,794$7.40$13,275.60View SEC Filing Icon  
11/28/2014Sell42,641$7.40$315,543.40View SEC Filing Icon  
11/25/2014Sell613$7.30$4,474.90View SEC Filing Icon  
11/5/2014Sell28,286$7.07$199,982.02View SEC Filing Icon  
10/31/2014Sell23,758$7.14$169,632.12View SEC Filing Icon  
9/8/2014Sell29,966$7.10$212,758.60View SEC Filing Icon  
See Full Table

George W. Lemaitre Buying and Selling Activity at LeMaitre Vascular

This chart shows George W Lemaitre's buying and selling at LeMaitre Vascular by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

LeMaitre Vascular Company Overview

LeMaitre Vascular logo
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes, which cut valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular patches, which are used for closure of vessels after surgical intervention; closure systems to attach vessels to one another with titanium clips instead of sutures; and surgical glue. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Read More

Today's Range

Now: $55.95
Low: $54.68
High: $56.25

50 Day Range

MA: $56.62
Low: $49.94
High: $63.33

2 Week Range

Now: $55.95
Low: $27.91
High: $64.50


184,433 shs

Average Volume

135,975 shs

Market Capitalization

$1.15 billion

P/E Ratio


Dividend Yield



Even Utah Is Falling in Love with Psychedelics
Nobody ever thinks of ultra-conservative Utah as a liberal stronghold. But one company there has already joined companies in California and Arizona in administering psychedelic treatments as a novel solution to depression. And that could mean the legal psychedelics market is poised to explode.
Here's how you could get in on the ground floor